HJB-97 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD2-BD1, BRD2 BD1, BRD2 BD2, BRD2 BD2, BRD3 BD1, BRD3 BD1, BRD3 BD2, BRD3 BD2, BRD4 BD1, BRD4 BD1, and BRD4 BD2.
HJB-97 can be used to study molecular mechanisms related to BET (Bromodomain and Extra-Terminal) family proteins.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.